|Bid||1.3000 x 3200|
|Ask||1.3300 x 1100|
|Day's Range||1.2500 - 1.3400|
|52 Week Range||1.2500 - 12.9900|
|Beta (5Y Monthly)||1.03|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The FDA bestows an Orphan Drug designation to Coherus (CHRS) and partner Junshi's toripalimab for the treatment of esophageal cancer.
Galera Therapeutics, Inc. (GRTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Good morning, investor! We’re kicking off Thursday with a dive into the biggest pre-market stock movers traders will want to watch today! Source: Shutterstock News moving stocks this morning includes earnings reports, clinical trial data, stock offerings, and more. Let’s get into those pre-market stock movers below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers InflaRx (NASDAQ:IFRX) stock is soaring more than 54% after announcing positive r